Authors: David Axe Fri, October 28, 2022 The new COVID-19 subvariants that are becoming dominant all over the world aren’t just more contagious than previous variants and subvariants—they might cause more severe […]
What do we know about covid vaccines and preventing transmission?
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o298 (Published 04 February 2022) Cite as: BMJ 2022;376:o298 Authors: Chris Stokel-Walker, Vaccines that work against SARS-CoV-2 have helped change the course of the pandemic by reducing illness and hospital admissions. […]
First case of postmortem study in a patient vaccinated against SARS-CoV-2
Author:TorstenHansenaUlfTitzeaNidhi Su AnnKulamadayil-HeidenreichbSabineGlombitzacJohannes, et. al. Highlights • We report on a patient with a single dose of vaccine against SARS-CoV-2. • He developed relevant serum titer levels but died 4 […]
The animal origin of SARS-CoV-2
Authors: Spyros Lytras1, Wei Xia2, Joseph Hughes1, Xiaowei Jiang3, David L. Robertson1 See all authors and affiliationsScience 27 Aug 2021:Vol. 373, Issue 6558, pp. 968-970 DOI: 10.1126/science.abh0117 Although first detected in December 2019, COVID-19 was inferred […]
The OC43 human coronavirus envelope protein is critical for infectious virus production and propagation in neuronal cells and is a determinant of neurovirulence and CNS pathology
Authors:Jenny K.Stodola1GuillaumeDubois1AlainLe CoupanecMarcDesforgesPierre J.Talbot Highlights Coronavirus structural envelope (E) protein specific motifs involved in protein-protein interaction or in homo-oligomeric ion channel formation are needed for optimal production of recombinant infectious […]